Featured Image

DIABETES + PAD
RESEARCH STUDY

Do you feel pain in your legs while walking and it stops when you rest? And do you have Type 2 Diabetes? If so, you can help in the development of future treatment for both conditions.

People affected by peripheral arterial disease (PAD) experience pain, cramping, or aching in the calves, thighs, or buttocks while walking or exercising, and these discomforts are relieved by rest. PAD is also a major risk factor for lower-extremity amputation, especially in patients with diabetes.

The STRIDE study is a research study that will look to see if a medicine called semaglutide has an affect on walking ability compared to with placebo in people with PAD and type 2 diabetes.

Complete this form to receive information about the STRIDE study.

Qualified participants will receive all study-related care and study medicines at no cost. 

You may qualify for the study if you meet the following criteria.

  • You are 18 years old or older.
  • You have peripheral arterial disease and type 2 diabetes.
  • You are able to come to our clinic for 8 visits and have 1 phone call over a period of about 59 weeks.

Featured Image
To contact the study coordinator, please enter the following information:
Please enter first name.
Please enter last name.
Please enter valid email.
Please enter valid mobile number.
Please enter valid zip code.
Your privacy is important to us. By clicking "Submit" you agree to our Privacy Policy and Terms of Use, and agree that we may retain the personal information you provide and share it with personnel involved in the study, or otherwise as described in the Privacy Policy, and we or our affiliates may contact you by phone using automated technology or pre-recorded voicemail or other means including but not limited to text messages (standard messaging rates may apply) regarding research studies.










This website stores cookies on your computer. These cookies are used to collect information about how you interact with our website and allow us to remember you.
Learn more Agree